No, many are not scheduled to arrive in FL. FL has done the

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks dbergh #67133
230
No, many are not scheduled to arrive in FL. FL has done the damage to itself. Trumpanzees can't, won't, help themselves.

Bio-voter suppression is well underway. Thank you.


The Delta variant is hitting red states hardest as the US's vaccine divide widens

Aria Bendix

https://www.businessinsider.com/delta-coronav...ide-2021-7

The Delta variant is sickening people most in unvaccinated, heavily Republican states.

Arkansas, Mississippi, Missouri, and Wyoming have seen upticks in cases and hospitalizations.


But the variant has had little effect in blue states such as Maine, New Hampshire, and Vermont.

The US's daily coronavirus cases have soared 60% in the past two weeks as the Delta variant strengthens its hold on the country. Delta now accounts for more than half of US cases, making it the dominant strain nationwide.

But the variant isn't hitting all states equally. Delta cases have risen primarily in states with low vaccination rates, which for the most part are heavily Republican — "red" states such as Arkansas, Mississippi, Missouri, and Wyoming. Overall, these states have seen higher upticks in daily cases and hospitalizations than "blue" states that voted Democratic in the 2020 election.

In Missouri, for instance , daily cases have risen around 75% in the past two weeks, from around 800 to 1,400 cases per day. Hospitalizations have also risen 34% during that time, from around 830 to 1,100 per day. Delta has made up almost 70% of all coronavirus cases there over the past two months, found data compiled by Scripps Research's Outbreak.info tracker. Less than half of Missouri residents (around 46%) have received at least one vaccine dose so far — well below the US average of 56%.

But Vermont, where almost 75% of residents have received at least one dose, has reported five daily cases and five daily hospitalizations in the past two weeks. Delta made up less than 1% of coronavirus cases there in the past two months.

Other blue states, such as Maine, New Hampshire, and Pennsylvania, have also reported some of the lowest case numbers and highest vaccination rates in the country. In each of these states, Delta has represented less than 10% of overall cases in the past two months, Outbreak.info showed.

"We've got to get away from the divisiveness," Anthony Fauci, the director of the National Institute of Allergy and Infectious Disease, told ABC on Sunday — a reference to the way the US's vaccine divide falls along political lines.

Viruses, Fauci added, "don't know the difference between a Democrat, a Republican, or an Independent."

Republicans are less likely than Democrats to trust vaccines


Data collected by The New York Times showed that 34% of people are fully vaccinated in an average US county that voted for Donald Trump, whereas 45% of people are fully vaccinated in an average county that voted for Joe Biden.

There are reasons the vaccination rates are stalling in red states. For one, Republicans are more likely to believe that vaccines aren't safe or that the shots aren't necessary to protect their health, indicated a June survey from the Kaiser Family Foundation.

Additionally, Republican states also tend to be more rural, so access to shots may still prevent some people in those areas from getting immunized.

In Arkansas, for instance , around 42% of counties are rural. Research from Boston Children's Hospital suggests that some Arkansas counties qualify as "vaccine deserts," with the nearest COVID-19 vaccination site more than a 15-minute drive away. Just 43% of Arkansas residents have received at least one vaccine dose.

But the state's health director, Dr. José Romero, blamed the low vaccination rate on widespread vaccine hesitancy — not lack of access. The Kaiser Family Foundation survey found that rural residents were also significantly more vaccine hesitant than urban or suburban residents.

"We've done everything we can," Romero told Insider. "We've made the vaccine available. We've gone the extra mile to make it pretty much on demand if you want it."

Delta has made up nearly 40% of Arkansas' cases over the past two months — among the highest shares in the country. Romero said he has tried to remind residents that the variant poses "a much greater threat" than the original coronavirus strain.

An analysis from Public Health England found that Delta was associated with a 60% increased risk of household transmission relative to the Alpha variant discovered in the UK, though more recent estimates suggested that the difference was closer to 40%. The Alpha variant is already about 50% more transmissible than the original strain, the Centers for Disease Control and Prevention said.

Researchers in Scotland also found that getting infected with the Delta variant doubled the risk of hospital admission relative to Alpha. (Previous studies have suggested that the Alpha variant may be 30% to 70% deadlier than the original strain.)

Vaccines, of course, significantly lower that risk, but it's important to complete the full course. New research suggested that partially vaccinated people are more vulnerable to symptomatic Delta infections than they might be to other strains. A study published last week in the journal Nature found that a single dose of Pfizer's vaccine was either weakly or not at all effective against the variant.

"It's very clear that this is a nasty variant," Fauci told ABC. "It has a much greater capability of transmitting from person to person."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 304

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 39

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 421

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 212

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 0

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 264

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 264

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Dar Global Eyes Dubai for Strategic Real Estate Moves

Updated Category News Views 0

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 53

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
General Dynamics (GD): Navigating Aerospace Headwinds and Opportunities

Updated Category News Views 209

General Dynamics: Current Market Dynamics General Dynamics Corporation (NYSE: GD) is widely recognized for its pivotal role in the aerospace and defense sectors. The company has a strong reputation, particularly for producing Gulfstream jets, alongside its diverse range of military and marine systems. Despite its established position, General Dynamics has been...

Continue Reading
SunCar Technology Group Inc. Enters NASDAQ Golden Dragon Index

Updated Category News Views 74

SunCar Technology Group Inc. Achieves Milestone Inclusion SunCar Technology Group Inc. (NASDAQ: SDA), a prominent player in the cloud-based B2B automotive services and insurance sector, proudly announces its recent addition to the NASDAQ Golden Dragon China Index. This significant achievement illustrates the company's upward journey and strengthens its market positioning....

Continue Reading
Strategic Investment by BrainsWay to Enhance Mental Health Solutions

Updated Category News Views 165

BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...

Continue Reading
Future Projections: Cosmetic Surgery Market Growth Insights

Updated Category News Views 97

The Expanding Cosmetic Surgery Market The cosmetic surgery market is anticipated to experience significant growth over the coming years, with projections indicating an increase from USD 56.98 billion in 2024 to approximately USD 83.34 billion by 2034. This impressive growth represents a compound annual growth rate (CAGR) of 3.84% from 2024 to 2034, driven by a variety of...

Continue Reading